(Q46921352)

English

Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.

scientific article published on 31 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

1 reference

based on heuristic

inferred from title

John P Chamberland

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Christos Socrates Mantzoros

5

object named as

Christos S Mantzoros

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

author name string

Ioanna Gouni-Berthold

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Heiner K Berthold

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Wilhelm Krone

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

publication date

31 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

68

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

536-541

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Adiponectin and cardiovascular disease: response to therapeutic interventions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Adiponectin and adiponectin receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Diagnosing insulin resistance in the general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Genetic and environmental determinants of circulating resistin level in a community-based sample

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Relationship between serum adiponectin level and lipid composition in each lipoprotein fraction in adolescent children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Relationships between baseline serum leptin levels and 2-year changes in body mass index, blood pressure and metabolic parameters in Japanese male adolescents and middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03080.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2007.03080.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17973945

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46921352&oldid=1539280786"